Dokuz Eylül University Information Package / Courses Catalog

General Description

History

Dokuz Eylul University Oncology Department Translational Oncology Doctorate Program was established in 2016 with the approval of YÖK. Those who have a master's degree in Translational Oncology and Basic Oncology and graduates who are medical specialists or who have a doctorate in medicine have the opportunity to pursue a PhD in Translational Oncology.

Translational oncology is a process that evolves from basic laboratory research to develop new therapies for the treatment of cancer and requires an interdisciplinary structure that is constantly expanding and intertwined. Doctorate specialists who are competent in clinical studies in the field of oncology, which are few in our country, can work in Medical, Pharmaceuticals, Biotechnology, Biomedical Industry R&D Laboratories, R&D Institutes and Universities, can follow international scientific and technological developments, are open to innovation and are compatible with teamwork in result-oriented studies. The program is planned to be opened in order to train people and R&D personnel and to train competent managers and personnel who will ensure national development in the medical device and pharmaceutical sector.

In our department, faculty members from the basic sciences (Basic oncology, Biostatistics) and clinical branches (Medical Oncology, Pathology, Internal Medicine, General Surgery) of the Oncology Institute and Faculty of Medicine are located. The language of the program is Turkish.

Qualification Awarded

Translational Oncology Ph.D.

Level of Qualification

Third Level (PhD)

Specific Admission Requirements

Master's degree diploma. Minimum 0 average 80/100 or 3/4. At least 60 points from the national Graduate Entrance Examination (ALES) in related fields or at least 50 points from the Medical Specialization Examination (TUS), at least 55 from YDS foreign language exams or equivalent score from TOEFL etc., successful in the science exam to be held by the institute on related subjects be (at least 75 points). transcript.

Specific Arrangements for Recognition of Prior Learning (Formal, Non-Formal and Informal)

Successful students who have completed at least one semester in the graduate program of a higher education institution, from within or outside the University, can be admitted to the institutes through horizontal transfer. Students who successfully complete the postgraduate entrance exams may be exempted from the courses they have taken during their education in other institutes deemed appropriate by the institute administrative board upon the proposal of the department. However, the total credit of the exempted courses cannot be more than 1/3 of the credit required to complete the relevant program.

Qualification Requirements and Regulations

4 years, 2 semesters in 1 year, 16 weeks in each semester, 240 ECTS. To graduate from the program, it is necessary to take courses for 78 ECTS, receive 12 ECTS for specialization and complete the thesis work for 150 ECTS. Must complete 240 ECTS credits in total. Must complete each course with a minimum grade point average of 2.50/4.00 and a minimum grade of 2.50/4.00 (CB/S/TP).

Profile of the Programme

Translational oncology is a process that evolves from basic laboratory research that develops new therapies for the treatment of cancer and requires an interdisciplinary structure that is constantly expanding and intertwined. In addition to the development of new therapies, the yet unresolved foundations of cancer are among the reasons that force a new approach in this field. In addition to a new medical approach, it is also an important rapidly developing field of biomedical research due to its focus on therapy. PURPOSE OF THE PROGRAM: A small number of clinical studies in the field of oncology, which are competent in the field of clinical research, Medical, Pharmaceutical, Biotechnology, Biomedical Industry R&D Laboratories, R&D To train PhD scientists and R&D personnel who can take charge in Institutes and Universities, follow international scientific and technological developments, are open to innovation, and are compatible with teamwork in result-oriented studies, and to train competent managers and personnel who will ensure national development in the medical device and pharmaceutical industry.

Key Learning Outcomes

1	Has an understanding of the basic theoretical and updated information on translational oncology
2	Has an understanding of the basic theoretical and updated information on science education
3	Has an understanding of the basic laboratory information used in the field of translational oncology (Principles of basic laboratory instruments and methods, basic molecular biology methods , In vitro laboratory methods, In silico methods, Principles of molecular epidemiological research , application methods and principles of laboratory animal use in research)
4	Has an understanding of the advanced laboratory (pharmaceutical technologies, cancer technologies) information used in the field of translational oncology
5	Analysis: Critically analyze information. Possess the expertise in research systematic with a minimum level of supervision
6	Synthesis: Synthesize the information by taking different directions in the field of translational oncology and adapt to new situations. Evaluation: Critical evaluation of research in field of translational oncology
7	Data-base searching and management in field of translational oncology
8	Academic and scientific communication skills (Transfer information in academic and professional environments. Possess written, oral, and electronic communication skills, Write an article in the native/foreign language with a minimum of guidance, Transfer information acquired-contribution to education, basic teaching skills Work effectively within a group, Work in joint projects and take responsibilities)
9	Be able to perform works within the framework of the ethical rules in the field of translational oncology.
10	.Skills in basic laboratory techniques (measuring and detection techniques, sample preparation techniques, molecular biology and cell culture techniques, working with laboratory animals, biostatistics and bioinformatics)
11	Expertise in applying advanced techniques (pharmaceutical and cancer technologies etc) in line with interest and thesis topic.
12	Knowledgeable about the academic and philosophical information for graduate education.

Occupational Profiles of Graduates with Examples

Graduates of this program work in the public and private sectors.

Access to Further Studies

Graduates can apply for postdoctoral studies.

Course Structure Diagram with Credits

Semester	No	Course Unit Code	Course Unit Title	Course Unit Type	T	P	L	ECTS
The student must take 30 ECTS each semester. 150 ECTS out of a total of 240 ECTS must be thesis work. During the doctorate education, a total of 90 ECTS (including 12 ECTS Specialization Areas) must be completed in three semesters. Must take at least 20 ECTS from common courses (Research Culture, Research Methods and Transferable Skills) and 20 ECTS from Discipline-Based and Laboratory Skills courses during the course taking. In addition, they can take 20 ECTS courses from common courses, discipline-Based and Laboratory Skills courses and/or from other programs or institutions. In the 1st semester, the student; Research Topics Related to Thesis I, 2nd semester; Thesis-Related Research Topics II must be taken as a compulsory course. It is obligatory for the student to take an ethics course/course during the course period.
T: Theoretical P: Practice L: Laboratory B: Spring Semester G: Fall Semester H: Full Year
ALL COURSES
G	1	SBE 6025	QUALITATIVE RESEARCH METHODS	ELECTIVE	1	0	0	3
G	2	OKE 6011	CANCER EPIDEMIOLOGY	ELECTIVE	2	0	0	6
G	3	SBE 6054	DATA-BASE SEARCHING IN HEALTH SCIENCES AND EVIDENCE-BASED MEDICINE	ELECTIVE	1	0	0	3
G	4	SBE 6027	HISTORY AND PHILOSOPHY OF SCIENCE	ELECTIVE	1	0	0	3
G	5	OKE 6010	ADVANCED STATISTICAL METHODS SPECIAL FOR CANCER RESEARCH	ELECTIVE	2	0	0	6
G	6	TRO 6017	BIOINFORMATICS IN CANCER RESEARCH	ELECTIVE	1	0	0	3
G	7	TRO 6016	TRANSLATIONAL ONCOLOGY	ELECTIVE	2	0	0	6
G	8	TRO 6015	INDIVIDUALIZED MEDICINE AND TREATMENT METHODS IN CANCER	ELECTIVE	2	0	0	6
G	9	TRO 6014	PROTEOMICS	ELECTIVE	1	0	0	3
G	10	TRO 6013	CANCER BIOLOGY AND GENETICS	ELECTIVE	2	0	0	6
G	11	SBE 6081	MILESTONES OF SCIENTIFIC DISCOVERY	ELECTIVE	3	0	0	9
G	12	SBE 6080	INTERDISCIPLINARY PRODUCT DEVELOPMENT IN HEALTHCARE	ELECTIVE	3	0	0	9
G	13	TRO 6009	TRANSLATIONAL RESEARCH METHODS I	ELECTIVE	1	2	0	10
G	14	TRO 6012	MICROBIOME AND CANCER	ELECTIVE	1	0	0	3
G	15	TRO 6011	METABOLIC BIOLOGY IN CANCER	ELECTIVE	1	0	0	3
G	16	TRO 6300	RESEARCH SUBJECTS FOR THESIS II	REQUIRED	3	0	0	10
G	17	TRO 6200	RESEARCH SUBJECTS FOR THESIS I	REQUIRED	3	0	0	8
G	18	TRO 6199	THESIS STUDY	THESIS	0	0	0	150
G	19	TRO 6005	CANCER TECHNOLOGIES AND DRUG DEVELOPMENT	ELECTIVE	1	0	0	6
G	20	TRO 6003	TRANSLATIONAL PERSPECTIVES IN CANCER SURGERY AND LOCOREGIONAL THERAPY	ELECTIVE	1	0	0	6
G	21	TRO 6001	TUMOR MICROENVIRENMENT	ELECTIVE	1	0	0	6
G	22	SBE 6068	COMPUTER APPLIED STATISTICS	ELECTIVE	1	2	0	6
G	23	SBE 6071	PERSONAL DEVELOPMENT	ELECTIVE	1	0	0	3
G	24	SBE 6076	EXPERIMENTAL ANIMALS AND ADVANCED APPLICATION METHODS	ELECTIVE	1	2	0	6
G	25	BİO 6059	BASIC LABORATORY PRINCIPLES AND METHODS I	ELECTIVE	1	4	0	9
G	26	SBE 6075	GENDER EQUALITY	ELECTIVE	1	2	0	6
G	27	SBE 6061	RECORDING AND PRESENTING EXPERIMENTAL RESEARCH DATA	ELECTIVE	1	0	0	3
G	28	SBE 6078	ETHICS IN HEALTH SCIENCES II	REQUIRED	1	0	0	3
G	29	BEP 6001	SCIENTIFIC PRESENTATIONS	ELECTIVE	1	0	0	3
G	30	SBE 6079	PLANNING, CARRYING OUT AND EVALUATION OF EXPERIMENTAL RESEARCH PROJECTS	ELECTIVE	2	0	0	6
G	31	TBG 6100	MOLECULAR AND CELL BIOLOGY TECHIQUES I	ELECTIVE	2	2	0	9
G	32	FAR 6057	PRINCIPLES OF CLINICAL PHARMACOLOGY	ELECTIVE	1	0	0	8
G	33	FAR 6060	EXPERIMENTAL METHODS IN PHARMACOLOGY AND TOXICOLOGY	ELECTIVE	1	2	0	6
B	34	BYF 6067	IMAGING TECHNIQUES	ELECTIVE	1	2	0	6
B	35	SBE 6058	CREATIVITY, DISCOVERY AND INNOVATION IN SCIENCE	ELECTIVE	1	0	0	3
B	36	TRO 6002	TRANSLATIONAL PERSPECTIVES IN CANCER	ELECTIVE	1	0	0	6
B	37	TRO 6010	TRANSLATIONAL RESEARCH METHODS II	ELECTIVE	1	2	0	10
B	38	FAR 6061	PRINCIPLES OF CLINICAL TOXICOLOGY	ELECTIVE	1	2	0	6
B	39	TRO 6098	SPECIALTY AREA	EXPERTNESS	3	0	0	12
B	40	TBG 6095	CELL CULTURE TECHNIQUES	ELECTIVE	2	4	0	12
B	41	BİO 6060	BASIC LABORATORY PRINCIPLES AND METHODS II	ELECTIVE	2	2	0	9
B	42	TRO 6400	SEMINAR	SEMINAR	0	3	0	3
B	43	BİO 6061	ELECTROPHORESIS TECHNIQUES	ELECTIVE	1	2	0	6
B	44	TBG 6101	MOLECULAR AND CELL BIOLOGY TECHIQUES II	ELECTIVE	2	2	0	9
B	45	SBE 6070	MEDICAL EDUCATION: BASIC PRINCIPLES AND METHODS	ELECTIVE	1	0	0	3
B	46	SBE 6069	RESEARCH METHODS AND ADVANCED ANALYSIS TECHNIQUES IN HEALTH SCIENCES	ELECTIVE	3	0	0	9
B	47	TRO 6004	CANCEROMICS	ELECTIVE	1	0	0	6
B	48	SBE 6066	DEVELOPMENT OF ASSESSMENT TOOLS	ELECTIVE	1	0	0	3
B	49	SBE 6065	BIOMEDICAL MANAGEMENT	ELECTIVE	2	0	0	6
B	50	SBE 6062	HOW TO WRITE AND PUBLISH RESEARCH ARTICLES	ELECTIVE	1	0	0	3
B	51	TRO 6006	TRANSLATIONAL AND CLINICAL ONCOLOGY	ELECTIVE	3	0	0	15

Examination Regulations, Assessment and Grading

The assessment and evaluation methods applied for each course are defined in the Course Introduction Form, which is prepared by the relevant faculty member/s and included in the Information package. DEU regarding exams and course grades. The relevant articles of the Associate Degree, Undergraduate Education and Examination Regulations and the Institute's Teaching and Exam Application Principles are applied. In order to be successful in the course, it is necessary to get at least 75

Graduation Requirements

Third Cycle (Doctorate Degree) Program is comprised of courses, (at least 78 ECTS), field study (12 ECTS) and thesis (150 ECTS), in total 240 ECTS credits. Students must have minimum Cumulative Grade Point Average (CGPA) of 2.50/4.00 and completed all the courses with at least CB / S / TP

Mode of Study (Full-Time, Part-Time, E-Learning )

Full Tıme

Programme Director or Equivalent

Prof. Dr. Hülya ELLIDOKUZ
Dokuz Eylul University Oncology Institute
e-mail: hulyazeyda@gmail.com
Tel: 90.232.4122601

DEGREE PROGRAMMES